Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis

Interleukin-11 (IL-11) is a pleiotropic cytokine that regulates the growth and development of hematopoietic stem cells and decreases the proinflammatory mediators of cytokine and nitric oxide production. In animal models of arthritis, treatment with recombinant human IL-11 (rhIL-11) reduces both the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Moreland, Larry, Gugliotti, Ron, King, Kevin, Chase, Walter, Weisman, Michael, Greco, Thomas, Fife, Rose, Korn, Joseph, Simms, Robert, Tesser, John, Hillson, Jan, Caldwell, Jacques, Schnitzer, Thomas, Lyons, David, Schwertschlag, Ullrich
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2001
Aiheet:
Primary Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC34114/
https://ncbi.nlm.nih.gov/pubmed/11438043
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia